Thiopurine biology and pharmacology.
Aarbakke
J
J
Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Norway.
Janka-Schaub
G
G
Elion
G B
GB
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D001379:Azathioprine / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D003001:Cloning, Molecular; D005838:Genotype; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D015122:Mercaptopurine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D008780:Methyltransferases / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D011110:Polymorphism, Genetic / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D011687:Purines / Q000737:chemistry / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013866:Thioguanine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D011687:Purines; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D013866:Thioguanine; D001379:Azathioprine